KeyBanc analyst Scott Schoenhaus upgraded Health Catalyst (HCAT) to Overweight from Sector Weight with a $9 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on HCAT: Health Catalyst price target raised to $12 from $11 at Piper Sandler Health Catalyst price target raised to $9 from $7 at Stephens Health Catalyst price target raised to $10.50 from $9 at Citi Health Catalyst Reports Q3 Revenue Growth Amid Reduced Losses